GGrantIndex
Sort

53,477 grants matching addiction

Atherosclerosis in cocaine addiction: imaging risk with PET/MR

$752,116
Nelly Alia-Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA

Atherosclerosis in cocaine addiction: imaging risk with PET/MR

$752,116
Nelly Alia-Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA

Atherosclerosis in cocaine addiction: imaging risk with PET/MR

$752,065
Nelly Alia-Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA

Childhood and Adolescent Predictors of Substance Abuse in Emerging Adulthood

$751,848
Judy A Andrews · Oregon Research Institute · R01 · FY2010 · DA

Overdose Risk Management and Compensation in the Era of Naloxone

$751,845
Alexander S Bennett · New York University · R01 · FY2019 · DA

Discovery of Addiction-Related Genes with Advanced Mouse Resources

$751,802
Elissa J Chesler · Jackson Laboratory · R01 · FY2016 · DA

Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial

$751,582
Sara Becker · Brown University · R01 · FY2018 · DA

Integrating Addiction Research in Health Systems: The Addiction Research Network

$751,542
Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2016 · DA

Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation

$751,483
Stacey C Sigmon · University Of Vermont & St Agric College · R01 · FY2019 · DA

Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation

$751,483
Stacey C Sigmon · University Of Vermont & St Agric College · R01 · FY2021 · DA

Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation

$751,483
Stacey C Sigmon · University Of Vermont & St Agric College · R01 · FY2017 · DA

Project 1: Toxicity testing of New & Manipulated Tobacco Products

$751,426
Pamela I Clark · Univ Of Maryland, College Park · P50 · FY2017 · CA

Maternal Brain and Behavioral Responses to Infant Cues in Cocaine Exposed Mothers

$751,355
Lane Strathearn · Baylor College Of Medicine · R01 · FY2014 · DA

Molecular Pathogenesis of Multiple Myeloma

$751,353
Walter Michael Kuehl · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Changing our paths: Well-being and recovery among American Indians with opioid use disorder

$751,310
Brenna Greenfield · University Of Minnesota · R61 · FY2019 · DA

Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

$751,280
Julia H. Arnsten · Albert Einstein College Of Medicine · R01 · FY2020 · DA

Hub and Spoke Model to Improve Pharmacotherapy Use for Opioid Addiction and Promote Recovery

$751,239
Sharon Reif · Brandeis University · R33 · FY2018 · DA

How do cells eliminate unassembled cytocolic proteins?

$751,226
Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

The Role of HIV Proteins in Psychostimulant Abuse

$751,112
Aurelio Antonio Galli · University Of Alabama At Birmingham · R01 · FY2025 · DA

Integrating Addiction Treatment and Medical Care in a Commercial Health Plan

$751,007
Dennis McCarty · Oregon Health & Science University · R01 · FY2011 · DA

Origin of Cortical Species-specific Distinctions

$750,994
Pasko Rakic · Yale University · R37 · FY2022 · DA

Origin of Cortical Species-specific Distinctions

$750,994
Pasko Rakic · Yale University · R37 · FY2021 · DA

Origin of Cortical Species-specific Distinctions

$750,993
Pasko Rakic · Yale University · R37 · FY2020 · DA

Origin of Cortical Species-specific Distinctions

$750,993
Pasko Rakic · Yale University · R37 · FY2023 · DA

The role of momentary acute discrimination and cultural resilience in polysubstance use among adults from communities of color

$750,959
Jimi Huh · University Of Southern California · R01 · FY2023 · DA